Curis Inc vs. Repligen Corp
Repligen Corp (RGEN) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| CRIS | RGEN | |
|---|---|---|
| Market Cap | $7.83 million | $9.00 billion |
| Revenue (TTM) | $7.06 million | — |
| Net Income (TTM) | $-21,165,000 | — |
RGEN leads on 1 of 1 size & scale factors.
Valuation
| CRIS | RGEN | |
|---|---|---|
| Price / Book | 0.62 | — |
| Price / Sales | 1.11 | — |
CRIS and RGEN split the valuation factors evenly.
Profitability
| CRIS | RGEN | |
|---|---|---|
| Net Margin | -299.66% | — |
| Return on Equity | -166.56% | — |
CRIS and RGEN split the profitability factors evenly.
Risk & Sentiment
| CRIS | RGEN | |
|---|---|---|
| Short Interest | 73.01% | 7.13% |
RGEN leads on 1 of 1 risk & sentiment factors.
Dig deeper: CRIS overview, CRIS financials, RGEN overview, RGEN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.